questionsmedicales.fr
Bactéries
Proteobacteria
Betaproteobacteria
Burkholderiales
Burkholderiaceae
Burkholderiaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Burkholderiaceae : Questions médicales les plus fréquentes",
"headline": "Burkholderiaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Burkholderiaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Burkholderiales",
"url": "https://questionsmedicales.fr/mesh/D000073556",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiales",
"code": {
"@type": "MedicalCode",
"code": "D000073556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia",
"alternateName": "Burkholderia",
"url": "https://questionsmedicales.fr/mesh/D019117",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia",
"code": {
"@type": "MedicalCode",
"code": "D019117",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia complex",
"alternateName": "Burkholderia cepacia complex",
"url": "https://questionsmedicales.fr/mesh/D042602",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia complex",
"code": {
"@type": "MedicalCode",
"code": "D042602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cenocepacia",
"alternateName": "Burkholderia cenocepacia",
"url": "https://questionsmedicales.fr/mesh/D057508",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cenocepacia",
"code": {
"@type": "MedicalCode",
"code": "D057508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.490"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia cepacia",
"alternateName": "Burkholderia cepacia",
"url": "https://questionsmedicales.fr/mesh/D016956",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia cepacia",
"code": {
"@type": "MedicalCode",
"code": "D016956",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.110.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia gladioli",
"alternateName": "Burkholderia gladioli",
"url": "https://questionsmedicales.fr/mesh/D042725",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia gladioli",
"code": {
"@type": "MedicalCode",
"code": "D042725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.355"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia mallei",
"alternateName": "Burkholderia mallei",
"url": "https://questionsmedicales.fr/mesh/D042726",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia mallei",
"code": {
"@type": "MedicalCode",
"code": "D042726",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.477"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Burkholderia pseudomallei",
"alternateName": "Burkholderia pseudomallei",
"url": "https://questionsmedicales.fr/mesh/D016957",
"about": {
"@type": "MedicalCondition",
"name": "Burkholderia pseudomallei",
"code": {
"@type": "MedicalCode",
"code": "D016957",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.100.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Cupriavidus",
"alternateName": "Cupriavidus",
"url": "https://questionsmedicales.fr/mesh/D049921",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus",
"code": {
"@type": "MedicalCode",
"code": "D049921",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cupriavidus necator",
"alternateName": "Cupriavidus necator",
"url": "https://questionsmedicales.fr/mesh/D020118",
"about": {
"@type": "MedicalCondition",
"name": "Cupriavidus necator",
"code": {
"@type": "MedicalCode",
"code": "D020118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.200.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia",
"alternateName": "Ralstonia",
"url": "https://questionsmedicales.fr/mesh/D043367",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia",
"code": {
"@type": "MedicalCode",
"code": "D043367",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ralstonia pickettii",
"alternateName": "Ralstonia pickettii",
"url": "https://questionsmedicales.fr/mesh/D049920",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia pickettii",
"code": {
"@type": "MedicalCode",
"code": "D049920",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ralstonia solanacearum",
"alternateName": "Ralstonia solanacearum",
"url": "https://questionsmedicales.fr/mesh/D043368",
"about": {
"@type": "MedicalCondition",
"name": "Ralstonia solanacearum",
"code": {
"@type": "MedicalCode",
"code": "D043368",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.075.090.688.600.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Burkholderiaceae",
"alternateName": "Burkholderiaceae",
"code": {
"@type": "MedicalCode",
"code": "D042521",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yusuke Takashima",
"url": "https://questionsmedicales.fr/author/Yusuke%20Takashima",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Yousuke Degawa",
"url": "https://questionsmedicales.fr/author/Yousuke%20Degawa",
"affiliation": {
"@type": "Organization",
"name": "Sugadaira Research Station Mountain Science Center, University of Tsukuba."
}
},
{
"@type": "Person",
"name": "Tomoyasu Nishizawa",
"url": "https://questionsmedicales.fr/author/Tomoyasu%20Nishizawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Hiroyuki Ohta",
"url": "https://questionsmedicales.fr/author/Hiroyuki%20Ohta",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
},
{
"@type": "Person",
"name": "Kazuhiko Narisawa",
"url": "https://questionsmedicales.fr/author/Kazuhiko%20Narisawa",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A randomized controlled trial enhancing viral hepatitis testing in primary care via digital crowdsourced intervention.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35853995",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41746-022-00645-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Knowledge hardly translates to reality-A randomized controlled trial on sexual abuse prevention for girls with intellectual disabilities.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35928769",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpsyt.2022.886463"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of sigh in lateral position on postoperative atelectasis in adults assessed by lung ultrasound: a randomized, controlled trial.",
"datePublished": "2022-07-11",
"url": "https://questionsmedicales.fr/article/35820814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12871-022-01748-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mindfulness-Based Stress Reduction in Breast Cancer Survivors with Chronic Neuropathic Pain: A Randomized Controlled Trial.",
"datePublished": "2022-07-07",
"url": "https://questionsmedicales.fr/article/35845983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/4020550"
}
},
{
"@type": "ScholarlyArticle",
"name": "Caffeine Attenuates Electroacupuncture Effect on Pressure Pain Threshold and Tolerance in Healthy Individuals: A Randomized Controlled Trial.",
"datePublished": "2022-07-07",
"url": "https://questionsmedicales.fr/article/35873768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fneur.2022.859624"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Betaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020562"
},
{
"@type": "ListItem",
"position": 5,
"name": "Burkholderiales",
"item": "https://questionsmedicales.fr/mesh/D000073556"
},
{
"@type": "ListItem",
"position": 6,
"name": "Burkholderiaceae",
"item": "https://questionsmedicales.fr/mesh/D042521"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Burkholderiaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Burkholderiaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Burkholderiaceae",
"description": "Comment diagnostiquer une infection par Burkholderiaceae ?\nQuels tests sont utilisés pour identifier Burkholderia ?\nLes symptômes aident-ils au diagnostic ?\nLes tests sérologiques sont-ils utiles ?\nQuelle est l'importance de l'antibiogramme ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Burkholderiaceae",
"description": "Quels sont les symptômes d'une infection par Burkholderia ?\nLes infections pulmonaires sont-elles fréquentes ?\nBurkholderia peut-elle causer des infections cutanées ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de Burkholderia ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Burkholderiaceae",
"description": "Comment prévenir les infections par Burkholderia ?\nLes vaccinations sont-elles efficaces ?\nLes personnes à risque doivent-elles être surveillées ?\nLes mesures d'hygiène hospitalière sont-elles importantes ?\nLes équipements de protection individuelle sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Burkholderiaceae",
"description": "Quel est le traitement standard pour les infections par Burkholderia ?\nLes infections sont-elles résistantes aux antibiotiques ?\nDes traitements alternatifs existent-ils ?\nLe traitement préventif est-il possible ?\nQuelle est la durée du traitement antibiotique ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Burkholderiaceae",
"description": "Quelles sont les complications possibles d'une infection par Burkholderia ?\nLes infections peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nLes infections peuvent-elles entraîner des hospitalisations prolongées ?\nQuelles sont les séquelles possibles après une infection ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Burkholderiaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes patients atteints de cysticfibrose sont-ils à risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes travailleurs de la santé sont-ils exposés ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D042521?mesh_terms=Randomized+Controlled+Trials+as+Topic&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Burkholderiaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des cultures bactériennes et des tests de sensibilité aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Burkholderia ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des séquençages génétiques sont souvent utilisés pour l'identification."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter vers une infection, mais ne suffisent pas."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques peuvent aider, mais ne sont pas toujours fiables pour Burkholderia."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme est crucial pour déterminer la sensibilité aux antibiotiques des souches isolées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection par Burkholderia ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, toux, douleurs thoraciques et parfois des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Les infections pulmonaires sont-elles fréquentes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections pulmonaires, notamment chez les patients immunodéprimés, sont courantes."
}
},
{
"@type": "Question",
"name": "Burkholderia peut-elle causer des infections cutanées ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir, surtout après des blessures ou des brûlures."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent apparaître, mais ils sont moins fréquents et souvent graves."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de Burkholderia ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon l'espèce de Burkholderia et l'état du patient."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Burkholderia ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une bonne hygiène, des soins appropriés des plaies et l'évitement des contacts à risque."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles être surveillées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ou avec des maladies chroniques doivent être surveillées de près."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène hospitalière sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures strictes d'hygiène hospitalière sont essentielles pour prévenir les infections nosocomiales."
}
},
{
"@type": "Question",
"name": "Les équipements de protection individuelle sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation d'équipements de protection individuelle est recommandée dans les milieux à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour les infections par Burkholderia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut des antibiotiques comme la céftazidime ou le meropenem."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles résistantes aux antibiotiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines souches de Burkholderia montrent une résistance significative aux antibiotiques."
}
},
{
"@type": "Question",
"name": "Des traitements alternatifs existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs peuvent inclure des combinaisons d'antibiotiques ou des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il possible ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement préventif peut être envisagé pour les patients à risque élevé d'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement antibiotique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée du traitement varie, mais elle est généralement de 2 à 4 semaines selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection par Burkholderia ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des septicémies, des infections pulmonaires graves et des abcès."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être mortelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Burkholderia peuvent être mortelles, surtout chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, bien que rares, peuvent survenir, entraînant des séquelles."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles entraîner des hospitalisations prolongées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections graves par Burkholderia peuvent nécessiter des hospitalisations prolongées."
}
},
{
"@type": "Question",
"name": "Quelles sont les séquelles possibles après une infection ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les séquelles peuvent inclure des problèmes respiratoires chroniques ou des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, les maladies chroniques et les traumatismes."
}
},
{
"@type": "Question",
"name": "Les patients atteints de cysticfibrose sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients atteints de cysticfibrose sont particulièrement vulnérables aux infections par Burkholderia."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru d'infections en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils exposés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés à des souches résistantes dans les hôpitaux."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où Burkholderia est endémique peut augmenter le risque d'infection."
}
}
]
}
]
}
Despite the availability of hepatitis B virus (HBV) and hepatitis C virus (HCV) testing in primary care, testing rates in China remain low. Social media is an inexpensive means of disseminating inform...
People with intellectual disabilities (ID) are at higher risk of being sexually abused and developing psychiatric disorders in consequence. The effects of behavior prevention programs for children wit...
A group prevention program was developed and evaluated. One hundred and six girls aged from 8 to 12 years with mild ID were enrolled in a randomized controlled study, comparing the training to a sham ...
Girls from the intervention group (...
This is the first study that evaluates a behavioral prevention program on sexual abuse for children with ID on a high level of evidence. Group interventions empowering girls with ID to recognize abuse...
Postoperative atelectasis occurs in 90% of patients receiving general anesthesia. Recruitment maneuvers (RMs) are not always effective and frequently associated with barotrauma and hemodynamic instabi...
We conducted a prospective, randomized, controlled trial in adults with open abdominal surgery under general anesthesia lasting for 2 h or longer. Subjects were randomly allocated to either control gr...
Seventy patients were included in the analysis. Before recruitment, there was no significant difference in LUS scores, Cdyn and PaO...
Sigh in lateral position can effectively reduce postoperative atelectasis even without causing severe side effects. Further large-scale studies are necessary to evaluate it's long-term effects on pulm...
ChiCTR1900024379 . Registered 8 July 2019,....
The purpose of this study was to compare the effects of group-delivered mindfulness-based stress reduction as compared to a waitlist control group among breast cancer survivors living with CNP....
A randomized controlled trial design was applied, and outcomes collected included pain, emotional function, quality of life, and global impression of change....
A total of 98 women were randomized and included in analyses. The sample included 49 women in the mindfulness-based stress reduction group, and 49 women in the waitlist control group. The intervention...
Our randomized clinical trial did not find significant benefits of group-based mindfulness-based stress reduction for the management of CNP. The current study findings should be replicated and are imp...
The effect of caffeine on acupuncture analgesia in humans is unclear. This study aimed to investigate whether caffeine-containing beverage intake influences the effect of electroacupuncture (EA) on st...
A total of 40 healthy subjects were enrolled and randomly assigned to receive coffee containing moderate doses of caffeine (coffee group) or non-caffeinated juice (juice group) for 4 weeks. The primar...
At week 0, both groups showed increased PPT and PPTo and decreased NRS scores of heat stimuli and RIII reflex after EA, but HPT was not affected. After 4 weeks, the effects of EA on PPT and PPTo were ...
Moderate caffeine intake reduced the effects of EA on PPT and PPTo in healthy subjects....
Cancer-related pain is one of the primary symptoms of patients with hepatocellular carcinoma (HCC). Previous studies have shown that transcutaneous electrical acupoint stimulation (TEAS) is effective ...
This is a single-center clinical, prospective randomized controlled clinical trial protocol. 104 patients will be randomly divided into the observation group and the control group in a ratio of 1:1.In...
Results of this trial are expected to clarify the value of TEAS stimulation performed on specific points in the management of moderate to severe pain in HCC....
Chinese clinical trial registry, ChiCTR2100044615 (http://www.chictr.org.cn), Registered on 24 March 2021....
Relevant data of PARADIGM-HF reveals sacubitril/valsartan (SV) therapy led to a greater reduction in the risks of arrhythmia, and sudden cardiac death than angiotensin converting enzyme inhibitor (ACE...
RCTs focused on the difference in therapeutic outcomes between SV and ACEI/ARB were searched from PUBMED, EMBASE, ClinicalTrials.gov, and Cochrane Library. The results were extracted from each individ...
Our meta-analysis provides evidence that, compared with ACEI/ARB, SV can additionally reduce the risks of most arrhythmias, just the significant differences are revealed in reducing the risks of VT, s...
Multidomain lifestyle modification is considered an effective intervention for dementia prevention due to its multifactorial nature. Recognizing that participants' activity adherence is crucial for su...
The neutrophil-to-lymphocyte ratio (NLR) is a useful prognostic marker for various diseases and surgery-induced immunosuppression. While opioids are important in general anesthesia, the association be...
Patients were randomly assigned to two groups: Group P (n=40) or Group C (n=40). Patients in group P received ultrasound-guided paravertebral block (PVB) before surgery, and followed by sufentanil pat...
At 24 and 48 hours after surgery, a lower sufentanil consumption, and higher QoR-40 recovery scores were found in group P than in group C (P<0.05). In biochemical analyses, the values of NLR were lowe...
Opioid-sparing pain management strategies may affect postoperative immunosuppression and NLR could be a reliable indicator of opioid-related immunosuppression. Moreover, opioid-sparing pain management...
In this multicenter, observational, controlled open-label trial, researchers randomized 200 women with vulvovaginal candidiasis (VVC) to: Group 1, 6-days clotrimazole 2% vaginal cream once-daily plus ...